Nicholas Investment Partners, LP Axsome Therapeutics, Inc. Transaction History

Nicholas Investment Partners, LP

  • $1.04 Billion
  • Q3 2025

A detailed history of Nicholas Investment Partners, LP transactions in Axsome Therapeutics, Inc. stock. As of the latest transaction made, Nicholas Investment Partners, LP holds 48,657 shares of AXSM stock, worth $6.8 Million. This represents 0.57% of its overall portfolio holdings.

Number of Shares
48,657
Previous 42,154 15.43%
Holding current value
$6.8 Million
Previous $4.4 Million 34.3%
% of portfolio
0.57%
Previous 0.48%

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 14, 2025
BUY
$100.39 - $129.29 $652,836 - $840,772
6,503 Added 15.43%
48,657 $5.91 Million
Q2 2025

Aug 14, 2025
SELL
$95.65 - $116.49 $135,631 - $165,182
-1,418 Reduced 3.25%
42,154 $4.4 Million
Q1 2025

May 15, 2025
BUY
$80.05 - $137.75 $2.68 Million - $4.61 Million
33,437 Added 329.92%
43,572 $5.08 Million
Q3 2024

Nov 12, 2024
BUY
$78.93 - $95.84 $799,955 - $971,338
10,135 New
10,135 $910,000
Q1 2024

May 13, 2024
SELL
$69.39 - $97.64 $3.18 Million - $4.47 Million
-45,829 Reduced 55.45%
36,816 $2.94 Million
Q4 2023

Feb 07, 2024
SELL
$57.42 - $83.61 $17.9 Million - $26.1 Million
-312,335 Reduced 79.08%
82,645 $6.58 Million
Q3 2023

Nov 13, 2023
BUY
$69.25 - $82.21 $6,648 - $7,892
96 Added 0.02%
394,980 $27.6 Million
Q2 2023

Aug 09, 2023
BUY
$58.41 - $90.35 $3.18 Million - $4.92 Million
54,454 Added 16.0%
394,884 $28.4 Million
Q1 2023

May 11, 2023
BUY
$58.39 - $75.0 $8.18 Million - $10.5 Million
140,176 Added 70.0%
340,430 $21 Million
Q4 2022

Feb 10, 2023
BUY
$39.94 - $79.72 $8 Million - $16 Million
200,254 New
200,254 $15.4 Million
Q2 2021

Aug 10, 2021
SELL
$50.63 - $73.5 $7.02 Million - $10.2 Million
-138,571 Closed
0 $0
Q1 2021

May 14, 2021
SELL
$55.91 - $81.44 $3.85 Million - $5.61 Million
-68,881 Reduced 33.2%
138,571 $7.85 Million
Q4 2020

Feb 11, 2021
BUY
$66.31 - $86.52 $1.31 Million - $1.7 Million
19,696 Added 10.49%
207,452 $16.9 Million
Q3 2020

Nov 13, 2020
BUY
$68.34 - $85.84 $11.3 Million - $14.2 Million
165,355 Added 738.16%
187,756 $13.4 Million
Q2 2020

Aug 12, 2020
SELL
$49.87 - $98.69 $1.72 Million - $3.39 Million
-34,400 Reduced 60.56%
22,401 $1.84 Million
Q1 2020

May 13, 2020
BUY
$41.2 - $101.31 $1.83 Million - $4.49 Million
44,358 Added 356.49%
56,801 $3.34 Million
Q4 2019

Feb 13, 2020
BUY
$16.71 - $106.24 $207,922 - $1.32 Million
12,443 New
12,443 $1.29 Million

Others Institutions Holding AXSM

# of Institutions
422
Shares Held
37M
Call Options Held
752K
Put Options Held
567K
View Full List

About Axsome Therapeutics, Inc.

AXSM Quotes by TradingView
  • Ticker AXSM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 42,878,000
  • Market Cap $5.99B
  • Description
  • Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinic...
More about AXSM
Track This Portfolio

Track Nicholas Investment Partners, LP Portfolio

Follow Nicholas Investment Partners, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nicholas Investment Partners, LP, based on Form 13F filings with the SEC.

News

Stay updated on Nicholas Investment Partners, LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email